Scientists Develop a Molecule That Blocks a Key Alzheimer’s Disease Mechanism, Then Discover the Compound’s Target Is Linked to a Naturally Occurring Molecule Already Present in Human Blood, Opening a Potential New Path Toward Treatment
A significant amount of Alzheimer's research is looking at ways to tackle the harmful clumps of amyloid-beta protein that build up between neurons in the brains of people with the disease.